1. Goossens A., Schwers A., Vandenbroecke C., Maenhoudt M.,Bugyaki L., Pastoret PP, Werenne J.: Arch, internat. Physiol. Biochim., 90 (4), B 193. Antiviral efficiency of interferon in the bovine species: preliminary data on the activity in calves of bacterially produced human interferon, 1982.
2. Werenne J.: Ann. Méd. Vét. 121 93–122. L’interferon: perspective actuelles, 1982.
3. Wérenne J., Pastoret J.J., Vandenbroecke C., Schwers A., Gossens A., Bugyaki L., Maenhoudt M.,: The Biology of the Interferon System, Elsevier Science Publishers B.V. E. De Maeyer and H. Schellekens, editors, 419–424. Bacterially produced interferon as an antiviral in the bovine species, 1983.
4. Werenne J., Vandenbroecke C., Schwers A., Goossens A., Bugyaki L., Maenhoudt M., Pastoret P.P.,: J. IFN Research 5, 129–136. Antiviral effect of bacterially produced human interferon (Hu-IFN α2) against experimental vaccinia infection in calves, 1985.
5. Dagenais L, Pastoret P.P., Vandenbroecke C., Werenne J.J.: Archives of Virology, 70, 377–379. Susceptibility of bovine rotavirus to interferon, 1981.